[BBWI]

The primary catalyst is positive news regarding Citi upgrading Bath & Body Works to a Buy rating ahead of its second-quarter earnings release. Depending on the REPORTING calculation, take profit when it reaches $21.56, and cut losses if it falls below $17.93. The current price of $16.73 is lower than the provided stop-loss price of $17.93. Entry was considered in anticipation of a rebound while the price remains significantly suppressed despite favorable news. In terms of candle patterns, following a sharp decline on September 15, the magnitude of the drop moderated on September 16. RSI(14) is at 42.1, which is below the neutral zone but not at an oversold level. Moving averages are in a non-bullish alignment, and trading volume is 1.03 times the 20-day average with no particular abnormal signals. Citi's bullish report and the relatively low price level were correct assumptions. However, contrary to the predicted modest rise of 2.5%, an actual additional decline of -11.1% occurred. Even though technical indicators (RSI 42.1, irregular moving average alignment) did not show strong upward momentum, there was an excessive reliance on news. Furthermore, as the stock's prior history demonstrated, we failed to fully account for the possibility that the response to positive news could be limited. In future trades, rather than relying solely on positive news catalysts, I will more strictly examine: 1) whether technical indicators show clear bullish reversal signals (e.g., a strong RSI rebound, moving averages aligning in a bullish sequence), and 2) the stock's historical behavioral patterns in reacting to such catalysts. In particular, when the trend is unclear, such as in a non-bullish alignment ('비정배열') state, a conservative entry strategy should be considered, or a strategy of waiting for a clearer breakout signal should be applied. In the past, BBWI showed a modest short-term gain of +3.2% in response to similar news (August 26, 2026), whereas it showed declines of -1.8% and -1.6% in response to negative news (August 18, 2026, and August 7, 2026, respectively). This suggests that the stock may have idiosyncratic characteristics of showing a limited reaction to positive news rather than a strong upward surge.

Bath & Body Works Non‑GAAP EPS of $0.62 exceeded $0.38, revenue of $1.51B exceeded $10M, and the company raised its FY guidance, providing a positive earnings catalyst. I will buy at the current price of 17.58, take profit when the price reaches the resistance level of 21.34, and cut loss when the price falls to the support level of 17.43. The current price of 17.58 is close to the 20‑day low support level of 17.43, and with news that EPS and revenue significantly exceeded expectations and FY guidance was raised, we anticipate a rebound near the support and therefore buy. RSI(14)=32.2 (oversold), moving average misalignment (weak trend), volume 2.23 times the 20‑day average (volume surge), recent 7‑day change -8.5% (downtrend) Actual return of 10.1% significantly exceeded the forecasted return of 3.5%, and the price rose to the target of 21.34, satisfying the take-profit condition. The stop-loss level was never touched, indicating that risk management functioned adequately. News and technical indicators sufficiently reflected upside potential, but the magnitude of the rise was underestimated. In the next trade, we will more actively utilize oversold signals when the RSI is 30 or below, and combine a surge in trading volume with proximity to support to adjust entry timing. When setting the target price, we will consider a level slightly above the current resistance, and set the stop‑loss just below the support to minimize risk. On 2026‑08‑18, it declined -1.8%; on 2026‑08‑07, -1.6%; on 2026‑07‑16, -1.2%; and in the past, similar‑sized declines were observed after earnings announcements, which is similar to the current situation.